-39.2%
ONON vs GSK
+31.2%
-70.5%
-45.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -1.9% | +0.6% | -1.1% |
| 7D | -3.0% | -1.8% | -1.2% | -2.8% |
| 30D | -26.7% | -2.2% | -24.5% | -26.4% |
| 3M | -25.3% | -1.8% | -23.5% | -25.0% |
| 6M | -35.3% | -10.6% | -24.6% | -35.0% |
| YTD | -39.8% | +4.4% | -44.2% | -37.9% |
| 1Y | -39.2% | +30.4% | -69.6% | -33.7% |
| All | -39.2% | +31.2% | -70.5% | -33.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling